- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06818877
[Prøving av enhet som ikke er godkjent eller ryddet av U.S. FDA]
This study is testing ways to help children with cerebral palsy (CP) improve how their hands work. Investigators want to see if brain activity using a virtual reality (VR) program can make their hands work better. The program is called Hand and Bimanual Intensive Therapy Virtual Reality (HABIT-VR). Investigators will compare how well HABIT-VR works to a simple VR program.
In the study a VR game will be played and participants in the treatment group, will have hand muscles gently stimulated to help the joints move.
Studieoversikt
Status
Detaljert beskrivelse
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Ahad Behboodi, PhD
- Telefonnummer: 402-554-7525
- E-post: abehboodi@unomaha.edu
Studiesteder
-
-
Nebraska
-
Omaha, Nebraska, Forente stater, 68106
- Rekruttering
- University of Nebraska Medical Center, Munroe-Meyer Institute
-
Ta kontakt med:
- Dr. Andrea Cunha, PT, PhD
- Telefonnummer: 402-559-6219
- E-post: abaraldicunha@unmc.edu
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria
Children with cerebral palsy
- Aged 6 to 17
- Unilateral and bilateral cerebral palsy (Hemiplegic or Diplegic cerebral palsy)
- Manual Ability Classification System Score (MACS) between I-IV.
- Gross Motor Function Classification System (GMFCS) levels ranging from I to III.
- Ability to follow verbal instructions
Typically developing children
- Aged 6 to 17
- Good physical health
- Ability to follow verbal instructions
Exclusion Criteria
Children with cerebral palsy
- Other conditions leading to the inability to move the upper extremity or handle objects
- Visual impairments preventing the performance of intervention and testing tasks
- Received an intensive therapeutic intervention involving upper extremities, botulinum toxin in an upper extremity within the past 6 months, or any upper extremity surgery in the past year
Typically developing children
- Chronic illnesses or medical conditions that could impact their development
- Significant behavioral or emotional issues that could indicate developmental disorders or psychological conditions
- Diagnosed developmental disorders [e.g., autism, Attention-deficit/hyperactivity disorder (ADHD), learning disabilities]
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Ikke-randomisert
- Intervensjonsmodell: Crossover-oppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Ingen inngripen: Control Group
There is no intervention for this group.
Investigators will record healthy children's brain activity to train the virtual reality (VR) program to improve upper limb function.
|
|
|
Eksperimentell: Cerebral Palsy Group
Participants in the Cerebral Palsy Group (CP) will be split into two groups of two partici[ants.
Both groups will play some VR games while hand movements are tracked.
These groups will switch after approximately 2 hours.
The two groups are Condition 1 (standard HABIT in HABIT-VR camps and HABIT-VR in BCI-HABIT-VR camps) and Condition 2 (VR HABIT in HABIT-VR camps and BCI-augmented VR HABIT in BCI-HABIT-VR camps).
|
Recent research indicates that running a camp using virtual reality (VR) software designed for a technique called hand-arm bimanual Intensive Training (HABIT) can help improve movement planning and execution in children with cerebral palsy (CP).
In this study, investigators aim to combine brain activity monitoring (known as Brain-Computer Interface Neurofeedback, or BCI-NFT) to aid the rehabilitation of upper limb movements in children with CP.
Furthermore, this new VR system (BCI-HABIT-VR) effects on brain activity and arm movement skills will be compared to the traditional HABIT-VR program.
Andre navn:
Participants will engage in a virtual reality (VR) game designed to train upper limbs.
A wristband, called the Empatica E4, will be worn which will help measure various factors such as heart rate, sweat levels, and skin temperature.
Additionally, the upper limb movements during the game will be measured.
There will be no brain activity recording for this group.
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Assisting Hand Assessment
Tidsramme: From enrollment to the training sessions over two weeks and two assessment sessions within one week before and after the treatment
|
The Assisting Hand Assessment (AHA) is scored from 0 to 100 AHA-units, with higher scores indicating greater ability in using the affected in bi-manual tasks.
|
From enrollment to the training sessions over two weeks and two assessment sessions within one week before and after the treatment
|
|
Brain Cortical Activity Measurement by Waveguard Electroencephalogram Cap
Tidsramme: Baseline (first assessment session) to 2 weeks
|
Changes in a participant's brain cortical activity will be measured during the intervention using a an FDA-cleared WAVEGUARD (TM) EEG Cap and an eego amplifier.
|
Baseline (first assessment session) to 2 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Box and Block Test Time
Tidsramme: From enrollment to the training sessions over two weeks and two assessment sessions within one week before and after the treatment.
|
The Box and Block Test Time (BBT) will count the number of aparticipant can transfer from one compartment of a divided box to the other within 60 seconds.
More blocks indicates better hand function.
|
From enrollment to the training sessions over two weeks and two assessment sessions within one week before and after the treatment.
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Ahad Behboodi, PhD, University of Nebraska
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 0407-24-FB
- P20GM109090 (U.S. NIH-stipend/kontrakt)
- 1R15HD117277-01 (U.S. NIH-stipend/kontrakt)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .